Safety and activity of durvalumab + tremelimumab in immunotherapy (IMT)-retreated advanced NSCLC patients Meeting Abstract
| Authors: | Garon, E. B.; Spira, A. I.; Goldberg, S. B.; Chaft, J. E.; Papadimitrakopoulou, V.; Antonia, S. J.; Brahmer, J. R.; Camidge, D. R.; Powderly, J. D.; Wozniak, A. J.; Felip, E.; Gao, G. Z.; Englert, J. M.; Awad, M. M. |
| Abstract Title: | Safety and activity of durvalumab + tremelimumab in immunotherapy (IMT)-retreated advanced NSCLC patients |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 470s |
| Language: | English |
| ACCESSION: | WOS:000442916003214 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.9041 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9041 -- Source: Wos |
